BioHealth News Archive
Fulfilling the promise of bioscience: report from Milken Institute outlines steps for overcoming barriers to innovation in medical research
It's been almost a decade since the Human Genome Project was completed, yet despite the best efforts of thousands of scientists around the world,…
Read More
Events: Boston by the Numbers
BIO International Convention organizers are hoping for the usual surge in attendance provided by the Boston biotech community at the event scheduled for June…
Read More
Want Better Odds? Get a Pharma Corporate VC to Invest – Forbes
Pharma corporate venture was back in the biotech news today with the release of Burrill & Company’s June 2012 report. An interesting article by Vinay…
Read More
Rockville Economic Development Inc. appoints executive director
Laurie Boyer, president of the Maryland Economic Development Association, is the new executive director of Rockville Economic Development Inc. Boyer has more than 15…
Read More
BioPulse – New cancer center breaks ground
The State of Maryland's Pulse on the Bio Industry. {iframe}http://cl.publicaster.com/ViewInBrowser.aspx?pubids=7297%7c810%7c88281%7c72143&digest=IxuSUfKR0eryi579dsIj3g&sysid=1{/iframe}
Read More
Who’s on Biotech’s Endangered Species List? Mid-Sized Drug Developers | Xconomy
Only a few companies have ever been successful enough to call themselves Big Biotechs. If boards and shareholders lack vision and guts, we’ll look back…
Read More
Cleveland Clinic to help Notre Dame commercialize medical innovations
Following on the heels of two hospitals, the University of Notre Dame has become the first university to strike a collaboration with Cleveland Clinic…
Read More
Osiris becomes first company to market stem-cell therapy – Baltimore Business Journal
Osiris Therapeutics Inc. in Columbia has become the world’s first company to receive market approval for a manufactured stem cell product. Health Canada, the…
Read More
Emergent gets FDA approval for modified vaccine dosing – Washington Business Journal
Rockville-based Emergent BioSolutions Inc. , which makes the only vaccine licensed by the Food and Drug Administration to protect against anthrax infection, has received…
Read More
United Therapeutics to Own Even More of Downtown Silver Spring
United Therapeutics, which has has greatly expanded their downtown Silver Spring presence as of late, is reportedly set to purchase from the county the…
Read More
Human Genome Sciences adopts stockholder rights plan – Baltimore Business Journal
Human Genome Sciences Inc, which has rejected a hostile $13-per-share offer from GlaxoSmithKline, has adopted a short-term stockholder rights plan to fend off such…
Read More
Two INNoVATE Students Take First Place in Maryland Business Plan Competition ‹ Hopkins Happenings
When Adam Steele worked at the National Institute of Standards and Technology (NIST), he and two other colleagues invented a technology that Steele believed…
Read More
The top 5 complications of FDA medical device trials
“You do a really good job with complex trials.” We’re lucky to say that we’ve heard this from several clients over the years. But,…
Read More
Human Genome Sciences Board of Directors Unanimously Determines GlaxoSmithKline Unsolicited Tender Offer is Inadequate and Not in the Best Interests of Stockholders – MarketWatch
Human Genome Sciences, Inc.oday announced that its Board of Directors, after careful review and consideration with the assistance of the Company's management and financial…
Read More
About Capital Connection | Capital Connection
Capital ConnectionTM, one of the nation’s most respected industry conferences, brings together high-growth and innovative technology companies from some of the most noted technology…
Read More